Stock listing
NASDAQ:XBIO Xenetic Biosciences, Inc. Stock
Home listing (NASDAQ) of Xenetic Biosciences, Inc.
Follow Xenetic Biosciences, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:XBIO
$2.06 USD +0.01 (+0.5%)
Close on Nov 2, 2026
- Day range
- $2.00 – $2.26 USDNov 2, 2026
- Volume
- 29,671 sharesNov 2, 2026
- Market cap
- $4.83M USDAt the close on Nov 2, 2026 · price × 2.34M shares outstanding
- 52-week range
- $1.58 – $4.94 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $246,869 USDMedian day 26,800 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:XBIO · Home | $2.06 USD | +0.01 (+0.5%) | 29,671 | $2.09 | $2.259 | $2.00 | $2.05 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:XBIO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.06 | +0.01 | +0.5% | $2.09 | $2.259 | $2.00 | 29,671 | |
| $2.05 | -0.07 | -3.3% | $2.14 | $2.15 | $1.95 | 32,564 | |
| $2.12 | +0.02 | +1.0% | $2.12 | $2.21 | $2.08 | 33,875 | |
| $2.10 | +0.275 | +15.1% | $1.95 | $2.135 | $1.89 | 136,342 | |
| $1.825 | -0.025 | -1.4% | $1.81 | $1.90 | $1.781 | 10,103 | |
| $1.85 | +0.13 | +7.6% | $1.70 | $1.859 | $1.58 | 45,666 | |
| $1.72 | -0.21 | -10.9% | $1.90 | $1.90 | $1.72 | 22,100 | |
| $1.93 | -0.09 | -4.5% | $2.03 | $2.04 | $1.90 | 18,900 | |
| $2.02 | +0.02 | +1.0% | $2.00 | $2.03 | $1.97 | 6,800 | |
| $2.00 | +0.07 | +3.6% | $1.96 | $2.05 | $1.96 | 11,500 | |
| $1.93 | -0.06 | -3.0% | $1.93 | $1.95 | $1.85 | 10,100 | |
| $1.99 | -0.02 | -1.0% | $1.98 | $2.00 | $1.92 | 17,500 | |
| $2.01 | -0.09 | -4.3% | $2.09 | $2.10 | $1.885 | 51,400 | |
| $2.10 | 0.00 | 0.0% | $2.07 | $2.14 | $2.07 | 12,600 | |
| $2.10 | -0.02 | -0.9% | $2.14 | $2.175 | $2.04 | 33,900 | |
| $2.12 | -0.01 | -0.5% | $2.14 | $2.27 | $2.11 | 8,500 | |
| $2.13 | +0.01 | +0.5% | $2.195 | $2.231 | $2.13 | 10,200 | |
| $2.12 | -0.09 | -4.1% | $2.18 | $2.18 | $2.10 | 13,600 | |
| $2.21 | +0.09 | +4.2% | $2.11 | $2.21 | $2.11 | 15,600 | |
| $2.12 | -0.08 | -3.6% | $2.19 | $2.341 | $2.10 | 14,700 | |
| $2.20 | -0.04 | -1.8% | $2.23 | $2.29 | $2.19 | 9,500 | |
| $2.24 | 0.00 | 0.0% | $2.30 | $2.33 | $2.11 | 43,200 | |
| $2.24 | -0.08 | -3.4% | $2.335 | $2.335 | $2.21 | 13,400 | |
| $2.32 | +0.06 | +2.7% | $2.26 | $2.335 | $2.22 | 30,400 | |
| $2.26 | -0.07 | -3.0% | $2.34 | $2.35 | $2.25 | 12,300 | |
| $2.33 | -0.06 | -2.5% | $2.37 | $2.475 | $2.23 | 34,700 | |
| $2.39 | -0.08 | -3.2% | $2.42 | $2.53 | $2.33 | 50,700 | |
| $2.47 | -0.05 | -2.0% | $2.56 | $2.56 | $2.28 | 64,000 | |
| $2.52 | -0.05 | -1.9% | $2.65 | $2.65 | $2.43 | 90,300 | |
| $2.57 | -0.42 | -14.0% | $2.99 | $2.99 | $2.436 | 152,600 | |
| $2.99 | +0.22 | +7.9% | $2.81 | $3.10 | $2.80 | 145,600 | |
| $2.77 | +0.31 | +12.6% | $2.50 | $2.80 | $2.30 | 413,700 | |
| $2.46 | +0.27 | +12.3% | $2.27 | $2.46 | $2.15 | 667,700 | |
| $2.19 | -2.08 | -48.7% | $2.75 | $2.789 | $1.87 | 1,514,500 | |
| $4.27 | -0.06 | -1.4% | $4.33 | $4.33 | $4.088 | 5,900 | |
| $4.33 | +0.43 | +11.0% | $4.00 | $4.33 | $3.852 | 66,800 | |
| $3.90 | -0.17 | -4.2% | $4.07 | $4.11 | $3.837 | 37,700 | |
| $4.07 | -0.145 | -3.4% | $4.15 | $4.20 | $4.06 | 15,500 | |
| $4.215 | -0.065 | -1.5% | $4.26 | $4.30 | $4.11 | 26,800 | |
| $4.28 | -0.39 | -8.4% | $4.67 | $4.76 | $4.00 | 86,000 | |
| $4.67 | +0.04 | +0.9% | $4.73 | $4.904 | $4.41 | 79,200 | |
| $4.63 | +0.38 | +8.9% | $4.27 | $4.939 | $4.27 | 139,100 | |
| $4.25 | +0.02 | +0.5% | $4.23 | $4.432 | $4.08 | 24,900 | |
| $4.23 | +0.04 | +1.0% | $4.20 | $4.25 | $4.00 | 25,900 | |
| $4.19 | +0.21 | +5.3% | $3.99 | $4.30 | $3.954 | 30,200 | |
| $3.98 | +0.01 | +0.3% | $4.01 | $4.06 | $3.90 | 19,600 | |
| $3.97 | +0.11 | +2.8% | $3.91 | $4.00 | $3.86 | 23,900 | |
| $3.86 | +0.04 | +1.0% | $3.78 | $3.88 | $3.70 | 22,400 | |
| $3.82 | +0.01 | +0.3% | $3.81 | $3.82 | $3.58 | 27,364 | |
| $3.81 | +0.22 | +6.1% | $3.74 | $4.05 | $3.53 | 102,789 | |
| $3.59 | +0.20 | +5.9% | $3.36 | $3.73 | $3.18 | 84,256 | |
| $3.39 | +0.03 | +0.9% | $3.41 | $3.41 | $3.28 | 9,269 | |
| $3.36 | +0.11 | +3.4% | $3.24 | $3.36 | $3.18 | 14,551 | |
| $3.25 | -0.01 | -0.3% | $3.22 | $3.25 | $3.18 | 5,693 | |
| $3.26 | -0.02 | -0.6% | $3.27 | $3.27 | $3.18 | 10,738 | |
| $3.28 | -0.01 | -0.3% | $3.157 | $3.28 | $3.156 | 6,689 | |
| $3.29 | -0.01 | -0.3% | $3.28 | $3.30 | $3.11 | 11,390 | |
| $3.30 | +0.08 | +2.5% | $3.30 | $3.30 | $3.16 | 13,120 | |
| $3.22 | +0.13 | +4.2% | $3.09 | $3.29 | $3.06 | 22,317 | |
| $3.09 | -0.08 | -2.5% | $3.11 | $3.17 | $3.02 | 31,623 | |
| $3.17 | +0.32 | +11.2% | $2.87 | $3.25 | $2.78 | 814,133 | |
| $2.85 | -0.11 | -3.7% | $2.93 | $2.96 | $2.837 | 19,274 | |
| $2.96 | +0.15 | +5.3% | $2.85 | $2.97 | $2.73 | 65,809 | |
| $2.81 | +0.15 | +5.6% | $2.79 | $2.98 | $2.74 | 68,121 | |
| $2.66 | +0.125 | +4.9% | $2.712 | $2.79 | $2.481 | 128,921 |
- Ticker
- NASDAQ:XBIO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 15, 2026
Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells for Large B-Cell Lymphoma
Latest deck · Sep 16, 2026
Merger or Acquisition (September 2026)
Merger or acquisition · 25 slides
Latest news
Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells for Large B-Cell Lymphoma
Oct 15, 2026
Closed $2.01 (-4.3%) on Oct 15, 2026
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
Sep 16, 2026
Closed $2.19 (-48.7%) on Sep 16, 2026
Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform
Aug 7, 2026
Closed $3.17 (+11.2%) on Aug 7, 2026
Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma
Jun 4, 2026
Closed $3.43 (+2.7%) on Jun 4, 2026
Xenetic Biosciences Showcases Compelling ASCO 2026 Data Demonstrating DNase I Significantly Enhances CAR-T Cell Persistence, Tumor Control, and Survival
Jun 1, 2026
Closed $3.31 (+5.1%) on Jun 1, 2026
Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform
May 13, 2026
Closed $3.18 (+5.1%) on May 13, 2026
Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting
Apr 22, 2026
Closed $3.14 (+0.3%) on Apr 22, 2026
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
Mar 13, 2026
Closed $2.81 (+9.5%) on Mar 13, 2026
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
Dec 11, 2025
Closed $2.44 (+0.8%) on Dec 12, 2025
Decks
Merger or Acquisition (September 2026)
Merger or acquisition · 25 slides · Sep 16, 2026
Merger or Acquisition (September 2026)
Merger or acquisition · 26 slides · September 2026
Investor Presentation (June 2023)
Investor deck · 30 slides · Jun 6, 2023
Investor Presentation (September 2021)
Investor deck · 28 slides · Sep 13, 2021
Xenetic Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 11 in the last 12 months · 101 in all · newest Oct 15, 2026 · oldest 2019
- Decks
- 8 decks · latest Sep 16, 2026
Where Xenetic Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:XBIO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:XBIO | BOATS | United States | USD |
| Munich:3XB0 | Munich | Germany | EUR |
| gettex:3XB0 | gettex | Germany | EUR |
Log in to ask 6ix AI your own questions about Xenetic Biosciences, Inc.